These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36757013)

  • 21. Impact of
    Mavilia-Scranton MG; Wu GY; Dharan M
    J Clin Transl Hepatol; 2023 Jun; 11(3):670-674. PubMed ID: 36969902
    [No Abstract]   [Full Text] [Related]  

  • 22. Helicobacter pylori infection is not an independent risk factor of non-alcoholic fatty liver disease in China.
    Wang W; Fan M; Gong R; Zhang Y; Zeng J; Xu S; Lin R
    BMC Gastroenterol; 2022 Feb; 22(1):81. PubMed ID: 35209867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori infection among patients with alcoholic and nonalcoholic cirrhosis.
    Schmulson MJ; De León G; Kershenovich A; Vargas-Vorackova F; Kershenobich D
    Helicobacter; 1997 Sep; 2(3):149-51. PubMed ID: 9432344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori: an update and a practical approach.
    Chao D; Remi G
    J La State Med Soc; 2001 Nov; 153(11):540-6. PubMed ID: 11789856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between Helicobacter pylori with nonalcoholic fatty liver disease assessed by controlled attenuation parameter and other metabolic factors.
    Han YM; Lee J; Choi JM; Kwak MS; Yang JI; Chung SJ; Yim JY; Chung GE
    PLoS One; 2021; 16(12):e0260994. PubMed ID: 34898613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consensus on the management of Helicobacter pylori infection: Tongcheng, Anhui Province, 2003.
    ;
    Chin J Dig Dis; 2004; 5(4):186-8. PubMed ID: 15612890
    [No Abstract]   [Full Text] [Related]  

  • 27. Does Helicobacter pylori eradication therapy result in a platelet count improvement in adults with immune thrombocytopenic purpura regardless of H pylori infection? ASH evidence-based review 2008.
    Arnold DM; Stasi R
    Hematology Am Soc Hematol Educ Program; 2008; ():31-2. PubMed ID: 19074051
    [No Abstract]   [Full Text] [Related]  

  • 28. [Progress in research on the relationship between Helicobacter pylori infection and cardiovascular diseases and its risk factors].
    Tang BW; Wang XM; Wu J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Mar; 54(3):327-331. PubMed ID: 32187941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical importance of Helicobacter pylori infection in patients with diabetes mellitus].
    Bures J; Smahelová A; Kopácová M; Rejchrt S
    Vnitr Lek; 2004 May; 50(5):350-3. PubMed ID: 15305630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Helicobacter pylori and gastro-esophageal reflux disease: clinical considerations].
    Berrutti M; Fagoonee S; Astegiano M; Pellicano R; Rizzetto M
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):153-6. PubMed ID: 17557043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and treatment of Helicobacter pylori infection in peptic ulcer disease.
    Berg-Gulcher L; Fitzgerald M
    J Am Acad Nurse Pract; 1995 May; 7(5):233-5. PubMed ID: 7779488
    [No Abstract]   [Full Text] [Related]  

  • 32. Helicobacter pylori infection is associated with gallstones: Epidemiological survey in China.
    Zhang FM; Yu CH; Chen HT; Shen Z; Hu FL; Yuan XP; Xu GQ
    World J Gastroenterol; 2015 Aug; 21(29):8912-9. PubMed ID: 26269681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori highlights from the first Canadian Digestive Disease Week.
    Matisko A; Thomson AB
    Can J Gastroenterol; 1997; 11(1):71-6. PubMed ID: 9113803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-alcoholic fatty liver disease is not independently associated with Helicobacter pylori in a central European screening cohort.
    Wernly S; Wernly B; Semmler G; Völkerer A; Rezar R; Semmler L; Stickel F; Aigner E; Niederseer D; Datz C
    Minerva Med; 2022 Dec; 113(6):936-949. PubMed ID: 35384436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori and functional dyspepsia: an unsolved issue?
    Zullo A; Hassan C; De Francesco V; Repici A; Manta R; Tomao S; Annibale B; Vaira D
    World J Gastroenterol; 2014 Jul; 20(27):8957-63. PubMed ID: 25083068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Microcirculatory changes of gastric mucosa in patients with chronic H. pylori-associated erosive gastritis with non-alcoholic steatohepatitis during treatment].
    Svintsits'kyĭ AS; Solovŭova HA; Kuryk OH; Dolhaia NIe
    Lik Sprava; 2013 Mar; (2):48-56. PubMed ID: 24605610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori and autoimmune diseases.
    Faria C; Zakout R; Araújo M
    Biomed Pharmacother; 2013 May; 67(4):347-9. PubMed ID: 23583190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of helicobacter pylori eradication on sideropenic refractory anaemia in adolescent girls with Helicobacter pylori infection.
    Choe YH; Lee JE; Kim SK
    Acta Paediatr; 2000 Feb; 89(2):154-7. PubMed ID: 10709883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori.
    Lecube A; Valladares S; López-Cano C; Gutiérrez L; Ciudin A; Fort JM; Reñé JM; Matias-Guiu X; de Torres I; Bueno M; Pallarés J; Baena JA
    PLoS One; 2016; 11(11):e0166741. PubMed ID: 27893763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori: diseases, tests and treatment.
    Vaira U; Gatta L; Ricci C; D'Anna L; Iglioli MM
    Dig Liver Dis; 2001 Dec; 33(9):788-94. PubMed ID: 11838615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.